Moving Forward from “Fine Particle Fraction: The Good and the Bad”

Newman SP : Fine particle fraction: The good and the bad. J Aerosol Med Pulmon Drug Deliv. 2022; 35:2–10.

Sagalla RB , and Smaldone GC : Capturing the efficiency of vibrating mesh nebulizers: Minimizing upper airway deposition. J Aerosol Med Pulmon Drug Deliv. 2014; 27:341–348.

Tougas TP , Mitchell JP , and Lyapustina S , (eds). Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products. Springer, New York, 2013.

Tougas TP , Christopher D , Mitchell JP , Strickland H , Wyka B , Van Oort M , and Lyapustina: Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs). AAPS PharmSciTech. 2009;10;1276–1285.

Goodey AP , Tougas T , Christopher JD , Doub W , Lyapustina S , and Mitchell JP : The application of Abbreviated Impactor Measurement and Efficient Data Analysis in the lifecycle of an orally inhaled product: A roadmap. Pharm Forum. 2018; 44:671–684. Available at: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/pf-legacy-pdf/pf-2018_vol-44.pdf Visited April 25, 2022.

Goodey AP , Mitchell JP , Doub WH , and Christopher JD : The liability of relying on the fine particle dose (FPD) metric for quality control. Inhalation. 2021; 14:18–22.